Premium
HIGH RATE OF DURABLE COMPLETE REMISSION IN FOLLICULAR LYMPHOMA AFTER CD19 CAR‐T CELL IMMUNOTHERAPY
Author(s) -
Hirayama A.V.,
Gauthier J.,
Hay K.A.,
Voutsinas J.M.,
Wu Q.,
Sheih A.,
Purushe J.,
Pender B.S.,
Hawkins R.M.,
Vakil A.,
Phi T.,
Steinmetz R.N.,
Riddell S.R.,
Maloney D.G.,
Turtle C.J.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.127_2629
Subject(s) - medicine , follicular lymphoma , chemoimmunotherapy , fludarabine , lymphoma , cyclophosphamide , gastroenterology , immunotherapy , oncology , rituximab , immunology , surgery , chemotherapy , cancer